Aleksandr Pecherkin (@pecherkinalex) 's Twitter Profile
Aleksandr Pecherkin

@pecherkinalex

ID: 957336540258160641

calendar_today27-01-2018 19:36:32

30 Tweet

13 Followers

204 Following

Knowuro (@knowuro) 's Twitter Profile Photo

Hello #urology #residents! Do you know what Fraley Syndrome is? #knowuro #uroSoMe #uroresidency #uroresident #urologie #urores

Hello #urology #residents!

Do you know what Fraley Syndrome is? #knowuro

#uroSoMe #uroresidency #uroresident #urologie #urores
The Innovation | Medicine (@innov_medicine) 's Twitter Profile Photo

Antibiotics part 1/2 (via stephbeggs) #medtwitter #foamed #meded #pharmacology #antibiotics #Medstudenttwitter #Health #ScienceResearch #Science #innomed

Knowuro (@knowuro) 's Twitter Profile Photo

Hello #urology #residents! Learn all the different surgical approaches for 𝐮𝐫𝐞𝐭𝐞𝐫𝐚𝐥 𝐭𝐫𝐚𝐮𝐦𝐚. Remember transuretero-ureterostomy is an option in cases of extensive ureteral loss. Big thank you @goumasurologia for the ✨🎞️!! #urologie #surgery #ureteraltrauma

Top Biomedical Science (@imedverse) 's Twitter Profile Photo

Adult cancers: NICE guidance on assessment and referral The BMJ Top Biomedical Science #TipsForNewDocs #MedEd #MedTwitter #medicine #medical #medicare #health #healthcare #FOAMed #ClinicalPearl #clinicaltips #MedStudents #oncology #cancer #cancerawareness

Adult cancers:
NICE guidance on assessment and referral

<a href="/bmj_latest/">The BMJ</a> <a href="/imedverse/">Top Biomedical Science</a> #TipsForNewDocs #MedEd #MedTwitter #medicine #medical #medicare #health #healthcare #FOAMed #ClinicalPearl #clinicaltips #MedStudents #oncology #cancer #cancerawareness
Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

It is this time of the year again: TOP 10 GU Oncology clinical papers/trials in 2023: Some negative, some positive, but we learned from all! Feel free to add more & retweet & tag This is not an exhaustive list! OncoAlert @danafarber Dana-Farber_GU #OnwardFor2024

It is this time of the year again: TOP 10 GU Oncology clinical papers/trials in 2023:  Some negative, some positive, but we learned from all!  

Feel free to add more &amp; retweet &amp; tag 

This is not an exhaustive list!

<a href="/OncoAlert/">OncoAlert</a> @danafarber <a href="/DanaFarber/">Dana-Farber</a>_GU

#OnwardFor2024
Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembrolizumab new SOC for patients with metastatic #UC. Trial #EV302 displaced 30y Platinum-based combos ⏩ PFS benefit: 12.5 vs 6.3 mo (HR= 0.45) ⏩ OS benefit:

IT IS THIS TIME OF THE YEAR AGAIN!

TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024

1/ Enfortumab Vedotin (EV) + Pembrolizumab new SOC for patients with metastatic #UC. Trial #EV302 displaced 30y Platinum-based combos 
⏩ PFS benefit: 12.5 vs 6.3 mo (HR= 0.45)
⏩ OS benefit:
Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

And NOW, TOP 5 PROSTATE CANCER trials of 2024! 1) The ARANOTE trial shows darolutamide + ADT improves rPFS in mHSPC by 46%,--Benefits seen across all subgroups with a favorable safety profile. ⛹🏼‍♂️A new player for doublets in mHSPC! #ESMO24 Dr. Fred Saad silke gillessen

And NOW, TOP 5 PROSTATE CANCER trials of 2024!

1) The ARANOTE trial shows darolutamide + ADT improves rPFS in mHSPC by 46%,--Benefits seen across all subgroups with a favorable safety profile. 
⛹🏼‍♂️A new player for doublets in mHSPC!

#ESMO24 Dr. Fred Saad <a href="/Silke_Gillessen/">silke gillessen</a>